It has been reported that FANCD2 plays a dual role in CML progression, with overexpression promoting cell survival and propagation, and inhibition of FANCD2 foci by the BCR-ABL fusion gene leading to genome instability [35,36]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.